Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-021717
Filing Date
2021-06-21
Accepted
2021-06-21 16:29:59
Documents
5
Effectiveness Date
2021-06-21

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10025772_s8.htm S-8 70236
2 EXHIBIT 5.1 brhc10025772_ex5-1.htm EX-5.1 7232
3 EXHIBIT 23.1 brhc10025772_ex23-1.htm EX-23.1 2449
4 EXHIBIT 99.2 brhc10025772_ex99-2.htm EX-99.2 212667
5 image01.jpg GRAPHIC 2062
  Complete submission text file 0001140361-21-021717.txt   296492
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257239 | Film No.: 211030983
SIC: 2834 Pharmaceutical Preparations